Needham Maintains Buy on Merit Medical Systems, Raises Price Target to $93
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Mike Matson maintains a Buy rating on Merit Medical Systems (NASDAQ:MMSI) and raises the price target from $85 to $93.
July 01, 2024 | 5:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Needham analyst Mike Matson has maintained a Buy rating on Merit Medical Systems and increased the price target from $85 to $93.
The increase in the price target from $85 to $93 by a reputable analyst suggests positive expectations for Merit Medical Systems' future performance, likely leading to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100